Literature DB >> 23211230

Diagnostic work-up in cardiomyopathies: bridging the gap between clinical phenotypes and final diagnosis. A position statement from the ESC Working Group on Myocardial and Pericardial Diseases.

Claudio Rapezzi1, Eloisa Arbustini, Alida L P Caforio, Philippe Charron, Juan Gimeno-Blanes, Tiina Heliö, Ales Linhart, Jens Mogensen, Yigal Pinto, Arsen Ristic, Hubert Seggewiss, Gianfranco Sinagra, Luigi Tavazzi, Perry M Elliott.   

Abstract

In 2008, The ESC Working Group on Myocardial and Pericardial Diseases proposed an updated classification of cardiomyopathies based on morphological and functional phenotypes and subcategories of familial/genetic and non-familial/non-genetic disease. In this position statement, we propose a framework for the clinical approach to diagnosis in cardiomyopathies based on the recognition of diagnostic 'red flags' that can be used to guide rational selection of specialized tests including genetic analysis. The basic premise is that the adoption of a cardiomyopathy-specific mindset which combines conventional cardiological assessment with non-cardiac and molecular parameters increases diagnostic accuracy and thus improves advice and treatment for patients and families.

Entities:  

Keywords:  Cardiomyopathy; Diagnosis; Genotype; Phenotype

Mesh:

Substances:

Year:  2012        PMID: 23211230     DOI: 10.1093/eurheartj/ehs397

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  73 in total

Review 1.  Chromosomal regulation by MeCP2: structural and enzymatic considerations.

Authors:  N J Bowen; M B Palmer; P A Wade
Journal:  Cell Mol Life Sci       Date:  2004-09       Impact factor: 9.261

2.  [The 2014 ESC guidelines on the diagnosis and management of hypertrophic cardiomyopathy : what is new?].

Authors:  B Maisch; H Mahrholdt
Journal:  Herz       Date:  2014-12       Impact factor: 1.443

Review 3.  Management of survivors of cardiac arrest - the importance of genetic investigation.

Authors:  Peter J Schwartz; Federica Dagradi
Journal:  Nat Rev Cardiol       Date:  2016-07-07       Impact factor: 32.419

4.  A highly accurate method for quantifying LVNC cardiomyophaty.

Authors:  Gregorio Bernabé; José D Casanova; Guillem Casas; Josefa Gonzάlez-Carrillo
Journal:  AMIA Annu Symp Proc       Date:  2021-01-25

Review 5.  [Genetic testing to prevent sudden cardiac death].

Authors:  B Stallmeyer; S Dittmann; E Schulze-Bahr
Journal:  Internist (Berl)       Date:  2018-08       Impact factor: 0.743

Review 6.  Role of non-invasive imaging in the work-up of cardiomyopathies.

Authors:  Lakshmi S Tummala; Raymond K Young; Tania Singh; Sandeep Jani; Monvadi B Srichai
Journal:  Curr Atheroscler Rep       Date:  2015-03       Impact factor: 5.113

7.  Familial dilated cardiomyopathy. Clinical and genetic characteristics.

Authors:  A Serio; N Narula; T Kodama; V Favalli; E Arbustini
Journal:  Herz       Date:  2012-12       Impact factor: 1.443

Review 8.  Cardiac amyloidosis: the great pretender.

Authors:  Claudio Rapezzi; Massimiliano Lorenzini; Simone Longhi; Agnese Milandri; Christian Gagliardi; Ilaria Bartolomei; Fabrizio Salvi; Mathew S Maurer
Journal:  Heart Fail Rev       Date:  2015-03       Impact factor: 4.214

Review 9.  Current state of the art and future of myectomy.

Authors:  Magdi H Yacoub; Ahmed Afifi; Hesham Saad; Heba Aguib; Ahmed ElGuindy
Journal:  Ann Cardiothorac Surg       Date:  2017-07

10.  A Novel Missense Mutation p.Gly162Glu of the Gene MYL2 Involved in Hypertrophic Cardiomyopathy: A Pedigree Analysis of a Proband.

Authors:  Pauline Renaudin; Alexandre Janin; Gilles Millat; Philippe Chevalier
Journal:  Mol Diagn Ther       Date:  2018-04       Impact factor: 4.074

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.